{
  "query": "adverse number previously reaction",
  "studies": {
    "protocolSection": [
      {
        "identificationModule": {
          "nctId": "NCT02839681",
          "briefTitle": "Anti-Mesothelin Antibody Drug Conjugate Anetumab Ravtansine for Mesothelin Expressing Lung Adenocarcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-07-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-07-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lung Neoplasms"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06674382",
          "briefTitle": "Haplo-HSCT for Myelofibrosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-01-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Myelofibrosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 39,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02149329",
          "briefTitle": "Short Versus Extended Antibiotic Treatment With a Carbapenem for High-risk Febrile Neutropenia in Hematology Patients With FUO"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-08-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Febrile Neutropenia", "Hematological Malignancy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 276,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02989857",
          "briefTitle": "Study of AG-120 in Previously Treated Advanced Cholangiocarcinoma With IDH1 Mutations (ClarIDHy)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-02-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-05-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Advanced Cholangiocarcinoma", "Metastatic Cholangiocarcinoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 187,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05770037",
          "briefTitle": "DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive Cancers"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-12-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2029-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Haematological Malignancy", "Malignant Neoplasm", "Lymphoproliferative Disorders", "Neoplasms by Histologic Type", "Neoplasms by Site", "Cancer", "Anaplastic Large Cell Lymphoma", "Lymphoma", "Renal Cell Carcinoma", "Neuroblastoma", "Solid Tumour"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03874156",
          "briefTitle": "MUscle Side-Effects of Atorvastatin in Coronary Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-03-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-12-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Statin Adverse Reaction"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 77,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06977165",
          "briefTitle": "Investigating the Impact of Sepsis Phenotypes on Antibiotic Treatment in Patients With Severe Pneumonia and Sepsis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-09-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-09-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Respiration Disorders", "Respiratory Failure", "Sepsis", "Infection in ICU", "Pneumonia"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 119,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00663702",
          "briefTitle": "Phase IIIB Switching From Intravenous to Subcutaneous Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-05"
          },
          "completionDateStruct": {
            "date": "2012-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Arthritis, Rheumatoid"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 123,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03903822",
          "briefTitle": "Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic Dermatitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-05-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-05-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Atopic Dermatitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 292,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03087929",
          "briefTitle": "Follow-up Trial of Rituximab Interferon Transplant Trial: Study Drug-Rituximab and Alpha Interferon"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-09-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-03-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lymphoma, Follicular"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00001575",
          "briefTitle": "Anti-Tac(90 Y-HAT) to Treat Hodgkin's Disease, Non-Hodgkin's Lymphoma and Lymphoid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "1997-04"
          },
          "completionDateStruct": {
            "date": "2013-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Hodgkin's Disease", "Lymphoma, Non-Hodgkin"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 87,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03653975",
          "briefTitle": "Clinical Features and Potential Etiology of Epilepsy and Nodding Syndrome in the Mahenge Area, Ulanga District"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Nodding Syndrome", "Epilepsy", "Onchocerciasis", "Cognitive Impairment"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 250,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "3 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02012153",
          "briefTitle": "Mesenchymal Stromal Cells in Kidney Transplant Recipients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-12-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-05-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Kidney Transplant Rejection"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 3,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03382496",
          "briefTitle": "Observational Study for Lung Cancer Patients Treated With Nivolumab"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-10-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-12-23",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lung Cancer"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 1462,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06815003",
          "briefTitle": "Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-04-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-10-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Lymphoblastic Leukemia", "Acute Myeloid Leukemia", "Chronic Myelomonocytic Leukemia", "Graft Versus Host Disease", "Myelodysplastic Syndrome", "Myeloproliferative Neoplasm"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 35,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01013350",
          "briefTitle": "Prospective Observational Long-term Safety Registry of Multiple Sclerosis Participants Who Have Participated in Cladribine Clinical Trials"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-11-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-10-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Sclerosis"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 1161,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01967888",
          "briefTitle": "Efficacy and Safety of Reparixin in Pancreatic Islet Auto-transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Pancreatectomy for Chronic Pancreatitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 104,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01970865",
          "briefTitle": "A Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular Alterations"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-01-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-05-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "ALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLC"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 364,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03405441",
          "briefTitle": "A Study to Investigate Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of JNJ-55375515 in Healthy Male Participants"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-01-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-09-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Healthy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 42,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "MALE",
          "minimumAge": "18 Years",
          "maximumAge": "54 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03381196",
          "briefTitle": "A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Non-Hospitalized Participants With Influenza A Infection Who Are at Risk of Developing Complications"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-01-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-08-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Influenza A"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 553,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "13 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05081986",
          "briefTitle": "Repeated iTBS Cycloserine Motor Plasticity"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-08-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-02-23",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Motor Activity"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01266031",
          "briefTitle": "Phase I/II Adaptive Randomized Trial of Bevacizumab Versus Bevacizumab Plus Vorinostat in Adults With Recurrent Glioblastoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-07-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-01-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Malignant Glioma", "Recurrent Glioblastoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 96,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00214422",
          "briefTitle": "Intensity Modulated Radiation Therapy for Prostate Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-09-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-04-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Prostate Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 19,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years",
          "maximumAge": "90 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04681729",
          "briefTitle": "Dupilumab for the Treatment of Chronic Inducible Cold Urticaria in Patients Who Remain Symptomatic Despite the Use of H1-antihistamine (LIBERTY-CINDU CUrIADS)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-12-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-04-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cold Urticaria"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 82,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06572631",
          "briefTitle": "Multi-antigen Specific CD8+ T Cells With Decitabine and Lymphodepleting Chemotherapy for the Treatment of Patients With Relapsed or Refractory AML or MDS Following an Allogeneic Hematopoietic Cell Transplantation From a Matched Donor"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-06-07",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-12-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Recurrent Acute Myeloid Leukemia", "Recurrent Myelodysplastic Syndrome", "Refractory Acute Myeloid Leukemia", "Refractory Myelodysplastic Syndrome"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00520494",
          "briefTitle": "Efficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary Immunodeficiency"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-03"
          },
          "completionDateStruct": {
            "date": "2008-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Common Variable Immunodeficiency", "Agammaglobulinemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 18,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Year",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06003283",
          "briefTitle": "Tapering of Rituximab Based on Interval Prolongation Compared to Disease Activity-guided Dose Reduction in Patients With Rheumatoid Arthritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-01-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Rheumatoid Arthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 134,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00001379",
          "briefTitle": "Treatment and Natural History Study of Lymphomatoid Granulomatosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "1995-05-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-01-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Lymphomatoid Granulomatosis", "Granulomatosis, Lymphomatoid", "Non-Hodgkins Lymphoma", "Lymphoproliferative Disorder"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 94,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05867160",
          "briefTitle": "Adjunctive Anti-seizure Medication (ASM) Real World Evidence (RWE) Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-05-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-09-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Epilepsy"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 300,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01853618",
          "briefTitle": "Tremelimumab With Chemoembolization or Ablation for Liver Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-05-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-06-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Heptocellular Cancer", "Biliary Tract Neoplasms", "Liver Cancer", "Hepatocellular Carcinoma", "Biliary Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 61,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05011123",
          "briefTitle": "Study on an Investigational Yellow Fever Vaccine Compared With Stamaril in Adults in Europe and Asia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-10-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-04-23",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Yellow Fever"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 690,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "59 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00719680",
          "briefTitle": "Extension Study of Subcutaneous Immunoglobulin Human in Patients With Primary Immunodeficiency (PID)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-06"
          },
          "completionDateStruct": {
            "date": "2010-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Primary Immune Deficiency"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 21,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03277313",
          "briefTitle": "Efficacy, Safety, Tolerability, Immunogenicity and Pharmacokinetic Evaluation of HYQVIA in Pediatric PIDD Subjects"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-09-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-07-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Primary Immunodeficiency Diseases (PID)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 44,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years",
          "maximumAge": "15 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00603525",
          "briefTitle": "Investigating Clinical Efficacy of Ofatumumab in Adult Rheumatoid Arthritis (RA) Patients Who Had an Inadequate Response to TNF-α Antagonist Therapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-01"
          },
          "completionDateStruct": {
            "date": "2013-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Arthritis, Rheumatoid"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 169,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03233724",
          "briefTitle": "Oral Decitabine and Tetrahydrouridine as Epigenetic Priming for Pembrolizumab-Mediated Immune Checkpoint Blockade in Patients With Inoperable, or Unresectable Locally Advanced or Metastatic Non-Small Cell Lung Cancers and Esophageal Carcinomas"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-04-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-10-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Carcinoma, Non-Small-Cell Lung", "Lung Cancer", "Non-Small Cell Lung Cancer", "Carcinoma, Esophageal", "Malignant Pleural Mesotheliomas"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 9,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05641480",
          "briefTitle": "Technical R&D and Demonstration of Intelligent Medical Care in Alzheimer's Disease's Management"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-06-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Alzheimer Disease", "Subjective Cognitive Decline", "Mild Cognitive Impairment", "Mild Dementia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 150,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "55 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07313176",
          "briefTitle": "Long Term Effectiveness of Levodopa-Entacapone-Carbidopa Intestinal Gel in Participants With Advanced Parkinson's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2029-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Advanced Parkinson Disease"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 215,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00053482",
          "briefTitle": "Dose Study of ACAM2000 Smallpox Vaccine in Previously Vaccinated Adults"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2003-01"
          },
          "completionDateStruct": {
            "date": "2003-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Smallpox"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 357,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "28 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02669017",
          "briefTitle": "Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-03"
          },
          "completionDateStruct": {
            "date": "2019-02-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Non-Hodgkin Lymphoma", "Burkitt's Lymphoma", "Chronic Lymphocytic Leukemia", "Lymphoma, Large B-Cell, Diffuse", "Lymphoma, Follicular", "Lymphoma, Mantle-Cell", "Lymphoma, Marginal Zone", "Waldenstrom Macroglobulinemia", "Primary Mediastinal B-cell Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 183,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02990858",
          "briefTitle": "An Extension Protocol for Subjects Who Successfully Completed PRO140_CD02 or PRO140_CD02_Open Label Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-11-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-07-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Human Immunodeficiency Virus (HIV)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 43,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02757326",
          "briefTitle": "ABC294640 (Opaganib) in Refractory / Relapsed Multiple Myeloma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-12-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Myeloma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 13,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05017545",
          "briefTitle": "Carfilzomib and Belatacept for Desensitization"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-12-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-02-28",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Highly Sensitized Prospective Kidney Transplant Recipients"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00026793",
          "briefTitle": "Assessment of Blood Vessel Density in Kaposi's Sarcoma Lesions"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2001-04-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-12-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Kaposi's Sarcoma"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 29,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04206332",
          "briefTitle": "Trial to Evaluate CIS43LS in Healthy Adults"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-01-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-02-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Malaria"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 71,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03197025",
          "briefTitle": "Immunotherapy With E6 T Cell Receptor (TCR) T Cells for Vulvar High-Grade Squamous Intraepithelial Lesions"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-01-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-10-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Human Papillomavirus", "HPV-16", "High Grade Squamous Intraepithelial Lesion"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03718117",
          "briefTitle": "Descriptive Observational Study ALK-2016-CPHG"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-01-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-07-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["NSCLC", "Crizotinib", "ALK Gene Rearrangement or ROS1 Gene Rearrangement"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 73,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01402284",
          "briefTitle": "Carfilzomib, Lenalidomide, and Dexamethasone in New Multiple Myeloma Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-07-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-09-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Myeloma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 45,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05952804",
          "briefTitle": "IVIG for Infection Prevention After CAR-T-Cell Therapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-06-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-07-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Hematologic Malignancies"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 150,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03939910",
          "briefTitle": "Effect of Preemptive Pudendal Nerve Block Using Bupivacaine Versus Ropivacaine on Post-operative Pain After Posterior Vaginal Repair."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-06-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2021-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Post-operative Pain After Posterior Vaginal Repair"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 72,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "FEMALE",
          "minimumAge": "20 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02984397",
          "briefTitle": "Chronic Widespread Pain and White Blood Cell Activation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Widespread Chronic Pain"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 44,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "14 Years",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01572480",
          "briefTitle": "Carfilzomib, Lenalidomide, and Dexamethasone for Smoldering Multiple Myeloma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-05-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-02-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Myeloma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 55,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04699578",
          "briefTitle": "COVID-19 Infection and Fetal-neonatal Outcomes"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-12-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-05-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Covid19", "Obstetric Complication", "SARS-CoV Infection", "Preterm Birth", "Miscarriage", "Placenta Diseases"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 230,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03958656",
          "briefTitle": "T-cells Expressing an Anti-SLAMF7 CAR for Treating Multiple Myeloma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-06-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-01-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Myeloma-Multiple", "Myeloma, Plasma-Cell"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 13,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "73 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01851369",
          "briefTitle": "TRC102 and Temozolomide for Relapsed Solid Tumors and Lymphomas"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-07-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-08-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Lymphomas", "Solid Tumors", "NSCLC", "Metastatic Colon Carcinoma", "Granulosa Cell Ovarian Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 93,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "120 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06832748",
          "briefTitle": "Neck Movement Training in a Virtual Reality Headset for People with Neck Pain - a Feasibility Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-03",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2025-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Neck Pain"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03558178",
          "briefTitle": "The Effectiveness and Cost-effectiveness of Doin (Conduction Exercise) for Chronic Neck Pain"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-07-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-12-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Neck Pain"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 124,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "19 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05212610",
          "briefTitle": "Assessing Safety of Coronavirus Infection (COVID-19) Messenger RNA (mRNA) Vaccine Administration in the Setting of a Previous Adverse Reaction"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-03-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-03-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["COVID-19", "Corona Virus Infection"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 103,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02141074",
          "briefTitle": "Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-07-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-10-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Congenital Bleeding Disorder", "Haemophilia B"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 54,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "0 Years",
          "maximumAge": "6 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06856213",
          "briefTitle": "Study of Cetuximab Plus/Minus Weekly Paclitaxel After Progression To First-Line Pembrolizumab Plus Platinum-5FU in Subjects With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-06-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Recurrent / Metastatic Head and Neck Squamous Cell Carcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 65,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03672318",
          "briefTitle": "Study of ATLCAR.CD138 Cells for Relapsed/Refractory Multiple Myeloma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-01-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2039-08-18",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Multiple Myeloma", "Immune System Diseases"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 25,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04458922",
          "briefTitle": "Testing Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced Chondrosarcoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-10-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-13",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Central Chondrosarcoma, Grade 2", "Central Chondrosarcoma, Grade 3", "Dedifferentiated Chondrosarcoma", "Metastatic Clear Cell Sarcoma of Soft Tissue", "Metastatic Primary Central Chondrosarcoma", "Unresectable Primary Central Chondrosarcoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 27,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03357952",
          "briefTitle": "A Study of JNJ-63723283, an Anti-programmed Death-1 Monoclonal Antibody, Administered in Combination With Daratumumab, Compared With Daratumumab Alone in Participants With Relapsed or Refractory Multiple Myeloma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-11-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-11-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Myeloma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00354172",
          "briefTitle": "Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-02"
          },
          "completionDateStruct": {
            "date": "2008-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Leukemia", "Myelodysplastic Syndromes"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 16,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "45 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01905592",
          "briefTitle": "A Phase III Trial of Niraparib Versus Physician's Choice in HER2 Negative, Germline BRCA Mutation-positive Breast Cancer Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-02-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-10-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Neoplasms, Breast", "Carcinoma of Breast", "Human Epidermal Growth Factor 2 Negative Carcinoma of Breast", "BRCA1 Gene Mutation", "BRCA2 Gene Mutation", "Ovarian Neoplasms"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 216,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01688999",
          "briefTitle": "Cabozantinib for Advanced Urothelial Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-09-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-09-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Urothelial Carcinoma", "Urethral Neoplasms", "Urinary Bladder Neoplasms", "Kidney Neoplasms"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 69,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03852498",
          "briefTitle": "A Clinical Study to Assess the Efficacy and Safety of Gene Therapy for the Treatment of Cerebral Adrenoleukodystrophy (CALD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-01-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-07-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Cerebral Adrenoleukodystrophy (CALD)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 35,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01274507",
          "briefTitle": "A Study for Disease Profiling of Asthma and Chronic Obstructive Pulmonary Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-07"
          },
          "completionDateStruct": {
            "date": "2014-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Asthma", "Pulmonary Disease, Chronic Obstructive"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 328,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06609928",
          "briefTitle": "FH-FOLR1 Chimeric Antigen Receptor T Cell Therapy for Treating Pediatric Patients With Relapsed or Refractory Acute Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-02-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2042-10-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Recurrent Childhood Acute Myeloid Leukemia", "Refractory Childhood Acute Myeloid Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "6 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05834907",
          "briefTitle": "Hands and Hearts Together"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-03-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Parent-Child Relations", "Development, Infant", "Parenting", "Development, Child"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 249,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "8 Months"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02993757",
          "briefTitle": "Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Gardasil®"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-12-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-05-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Dengue Fever", "Dengue Hemorrhagic Fever", "Human Papillomavirus Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 528,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "9 Years",
          "maximumAge": "13 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04307134",
          "briefTitle": "Besponsa Post Marketing Surveillance Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-07-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hematologic Malignancy"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 108,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "19 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01326728",
          "briefTitle": "Relapsed Malignant Blood Cancer After Allogeneic Hematopoietic Stem Cell Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-03-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-07-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Myelogenous Leukemia", "Acute Myelogenous Leukemia", "Acute Lymphoblastic Leukemia", "Hodgkins Lymphoma", "Non-Hodgkins Lymphoma"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 56,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00263328",
          "briefTitle": "Extension Study Of Stage 1 Subjects Of Study A3921009 For The Prevention Of Acute Rejection In Kidney Transplant Patient"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-12"
          },
          "completionDateStruct": {
            "date": "2014-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Kidney Transplantation"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 46,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03932201",
          "briefTitle": "Evaluating Effectiveness and Long Term Safety of Damoctocog Alfa Pegol in Patients, Who Have Been Diagnosed With Hemophilia A"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-10-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-03-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Hemophilia A"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 371,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02733419",
          "briefTitle": "Efficacy, and Safety Study of Optimized Background Antiretroviral Regimen (OB) in Combination With Enfuvirtide in the Treatment-Experienced Participants With Human Immunodeficiency Virus-1 (HIV-1) Infection"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2004-12"
          },
          "completionDateStruct": {
            "date": "2008-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "HIV Infections"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 84,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05146830",
          "briefTitle": "A Long-Term Follow-Up Study of Participants With Cystinosis Who Previously Received CTNS-RD-04"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-11-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2036-11-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Cystinosis"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 50,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "14 Years",
          "maximumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00114738",
          "briefTitle": "EPOCH-R Chemotherapy Plus Bortezomib to Treat Mantle Cell Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-06-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-08-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Lymphoma, Mantle Cell", "Mantle Cell Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 53,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02417753",
          "briefTitle": "AZD9150, a STAT3 Antisense Oligonucleotide, in People With Malignant Ascites"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-04-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-04-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Ovarian Cancer", "Ovarian Neoplasms", "Ascites", "Gastrointestinal Cancer", "Gastrointestinal Neoplasms"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04152161",
          "briefTitle": "Bacille Calmette Guerin (BCG) Revaccination of Healthy Adolescents for the Prevention of Mycobacterium Tuberculosis Sustained Infection"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-10-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-05-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Tuberculosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1836,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "10 Years",
          "maximumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01264081",
          "briefTitle": "Lapatinib in Stage IV Melanoma With ERBB4 Mutations"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-05-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2013-11-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Malignant Melanoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 34,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02242942",
          "briefTitle": "Comparison of the Treatments of Obinutuzumab + Venetoclax Versus Obinutuzumab + Chlorambucil in Patients With Chronic Lymphocytic Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-12-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-08-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lymphocytic Leukemia, Chronic"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 445,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05216341",
          "briefTitle": "Study of OLP-1002 Injections for Reducing Moderate to Severe Pain Due to Osteoarthritis in Hip and/or Knee Joint"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-01-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-09-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Osteoarthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 134,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "35 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05844605",
          "briefTitle": "Prehabilitation, Rehabilitation and Comprehensive Approach to the Sequelae of Brain Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-06-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Brain Tumor"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04400994",
          "briefTitle": "IVIG With Rituximab vs Rituximab as First Line Treatment of Pemphigus"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-06-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Pemphigus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04745351",
          "briefTitle": "Study to Evaluate the Efficacy and Safety of Remdesivir in Participants With Severely Reduced Kidney Function Who Are Hospitalized for Coronavirus Disease 2019 (COVID-19)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-03-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-05-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 249,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02448810",
          "briefTitle": "Phase 2a Study of BAX69 and 5-FU/Leucovorin or Panitumumab Versus Standard of Care in Subjects With Metastatic Colorectal Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-06-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-02-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Metastatic Colorectal Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 115,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02293603",
          "briefTitle": "Dilated cardiomYopathy iNtervention With Allogeneic MyocardIally-regenerative Cells (DYNAMIC)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-11"
          },
          "completionDateStruct": {
            "date": "2020-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Dilated Cardiomyopathy (DCM)", "Ischemic Cardiomyopathy", "Nonischemic Cardiomyopathy", "Heart Failure"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 42,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01755559",
          "briefTitle": "Efficacy of Three ACTs for the Treatment of Falciparum Malaria in Maradi Niger"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-06"
          },
          "completionDateStruct": {
            "date": "2014-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Malaria"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 663,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Months",
          "maximumAge": "59 Months"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02546375",
          "briefTitle": "A Study To Describe The Real World Use Of Bosutinib In The UK And Netherlands"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-07-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-01-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Myeloid Leukaemia"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 87,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01989546",
          "briefTitle": "Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-02-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-03-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Advanced Ovarian Cancer", "Primary Peritoneal Cancer", "Advanced Breast Cancer", "Advanced Solid Tumors"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 9,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "120 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04150861",
          "briefTitle": "Rekovelle PK Trial in Chinese Women"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-06-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-12-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Infertility"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 24,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "FEMALE",
          "minimumAge": "21 Years",
          "maximumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03554473",
          "briefTitle": "M7824 and Topotecan or Temozolomide in Relapsed Small Cell Lung Cancers"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-09-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-03-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Carcinoma, Small Cell", "Lung Cancer", "Small Cell Lung Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 37,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02179515",
          "briefTitle": "Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-06-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-02-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Lung Cancer", "Breast Cancer", "Prostate Cancer", "Tumors (Others)", "Ovarian Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 38,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01750073",
          "briefTitle": "Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-12-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Estrogen Receptor Negative", "Estrogen Receptor Positive", "HER2/Neu Negative", "HER2/Neu Positive", "Invasive Breast Carcinoma", "Progesterone Receptor Negative", "Progesterone Receptor Positive", "Stage IA Breast Cancer", "Stage II Breast Cancer", "Stage IIA Breast Cancer", "Stage IIB Breast Cancer", "Stage III Breast Cancer", "Stage IIIA Breast Cancer", "Stage IIIB Breast Cancer", "Stage IIIC Breast Cancer", "Triple-Negative Breast Carcinoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 92,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "19 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00943202",
          "briefTitle": "Sanofi Pasteur, TIV + H1N1, Pediatric Population"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-08"
          },
          "completionDateStruct": {
            "date": "2010-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Influenza"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 531,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "6 Months",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06470737",
          "briefTitle": "Investigation of Corticospinal Excitability Aspects of Itch and Pain"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-07-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-10-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Itch", "Pain"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03092518",
          "briefTitle": "Heated Intraperitoneal Chemotherapy and Gastrectomy for Gastric Cancer With Positive Peritoneal Cytology"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-06-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-07-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Gastric Adenocarcinoma", "Esophagogastric Junction", "Gastric Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 27,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01593696",
          "briefTitle": "Anti-CD19 White Blood Cells for Children and Young Adults With B Cell Leukemia or Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-06-29",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-10-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["ALL", "B Cell Lymphoma", "Leukemia", "Large Cell Lymphoma", "Non-Hodgkin Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 53,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Year",
          "maximumAge": "30 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07060742",
          "briefTitle": "Study on the Use of Exergames to Support Older Adults With Psychosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-06-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-05-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Psychosis", "Exergaming", "Elderly"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 32,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00360568",
          "briefTitle": "Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's Subjects"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-06"
          },
          "completionDateStruct": {
            "date": "2012-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Dyskinesias", "Parkinson's Disease", "Severe Motor Fluctuations"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 62,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "30 Years"
        }
      }
    ],
    "protocolSection.1": [
      {
        "identificationModule": {
          "nctId": "NCT02944682",
          "briefTitle": "Household Air Pollution and Health: A Multi-country LPG Intervention Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-09-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-06-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Infant, Low Birth Weight"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 3640,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "79 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05009979",
          "briefTitle": "18F-DCFPyL PET/CT in Hepatocellular Carcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-01-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-11-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hepatocellular Carcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 8,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02151266",
          "briefTitle": "Exercise and Cognitive Retraining to Improve Cognition in Heart Failure."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-07"
          },
          "completionDateStruct": {
            "date": "2017-12-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Heart Failure"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 69,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01262872",
          "briefTitle": "Impact of GSK Biologicals' 2189242A Vaccine on Nasopharyngeal Carriage, Safety & Immunogenicity in Children & Infants"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-02-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2013-03-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Infections, Streptococcal"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1320,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "56 Days",
          "maximumAge": "4 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03030417",
          "briefTitle": "Indenoisoquinoline LMP744 in Adults With Relapsed Solid Tumors and Lymphomas"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-02-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-10-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Solid Tumors", "Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 36,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02356159",
          "briefTitle": "Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-09-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-03-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Myelodysplastic Syndromes", "Hodgkin's Lymphoma", "Non-Hodgkin's Lymphoma", "Acute Leukemia", "Multiple Myeloma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 34,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01574274",
          "briefTitle": "SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-06"
          },
          "completionDateStruct": {
            "date": "2027-07-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Lymphoblastic Leukemia", "Lymphoblastic Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 240,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "365 Days",
          "maximumAge": "21 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03546413",
          "briefTitle": "Follow up of LEAP Participants and Their Families"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-07-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-08-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Peanut Allergy"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 1868,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "0 Months"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02179125",
          "briefTitle": "Identifying REsponders and Exploring Mechanisms of ACTION of the Endobronchial Coil Treatment for Emphysema"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-03"
          },
          "completionDateStruct": {
            "date": "2019-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Obstructive Pulmonary Disease (COPD)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 48,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00124917",
          "briefTitle": "Phase I Study of Intensity Modulated Radiation Therapy for Prostate Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-07-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-05-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Prostate Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 6,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years",
          "maximumAge": "90 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06485115",
          "briefTitle": "Telerehabilitation in Progressive Multiple Sclerosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-06-30",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Progressive Multiple Sclerosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 78,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04969276",
          "briefTitle": "Study of a Quadrivalent High-Dose Influenza Vaccine and a Moderna COVID-19 Vaccine Administered Either Concomitantly or Singly in Participants 65 Years of Age and Older Previously Vaccinated With a 2-dose Schedule of Moderna COVID-19 Vaccine"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-07-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-02-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Influenza Immunization", "Healthy Volunteers"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 306,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01796613",
          "briefTitle": "Safety and Acceptability of Vaginal Rings That Protect Women From Unintended Pregnancy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-06"
          },
          "completionDateStruct": {
            "date": "2014-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Contraception"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 120,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "35 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03154983",
          "briefTitle": "The Clinical Research of Mesylate Apatinib Combined With Docetaxel and S-1 as the First-line Treatment of Metastatic Gastric Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-05-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Metastatic Gastric Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 48,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02859415",
          "briefTitle": "Continuous 24h Intravenous Infusion of Mithramycin, an Inhibitor of Cancer Stem Cell Signaling, in People With Primary Thoracic Malignancies or Carcinomas, Sarcomas or Germ Cell Neoplasms With Pleuropulmonary Metastases"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-08-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-12-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Esophageal Neoplasms", "Lung Neoplasms", "Mesothelioma", "Thymus Neoplasms", "Neoplasms, Germ Cell and Embryonal"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 3,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05459688",
          "briefTitle": "Open-Label Extension Study of Patients Previously Enrolled in Study CIN-107-124"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-04-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-11-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hypertension"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 175,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02261506",
          "briefTitle": "Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness: A Pilot RCT"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-10-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-10-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Bacteremia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 115,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01963611",
          "briefTitle": "Efficacy, Safety, and Tolerability of Plovamer Acetate (Pathway 1)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-10"
          },
          "completionDateStruct": {
            "date": "2015-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Relapsing Remitting Multiple Sclerosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 255,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00998309",
          "briefTitle": "Zithromax-SR 2g, Special Investigation (Regulatory Post Marketing Commitment Plan)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-10"
          },
          "completionDateStruct": {
            "date": "2011-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Bacterial Infections"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 502,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03394027",
          "briefTitle": "ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-01-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-10-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Triple Negative Breast Cancer", "Endometrial Cancer", "Hormone Receptor Positive, HER2 Negative Breast Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02295527",
          "briefTitle": "Functional Later Rehabilitation in Older Adults: Effectiveness of Physical Exercises"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-11"
          },
          "completionDateStruct": {
            "date": "2019-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Hip Fractures"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 82,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03830762",
          "briefTitle": "Xanamem™ in Healthy Elderly Subjects"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-01-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-01-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Safety", "Peripheral Neuropathy", "Cortisol", "Central Nervous System", "Cognitive Function", "Healthy Ageing", "Small Fibre Neuropathy", "Cerebrospinal Fluid", "Electrocardiography"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 42,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "50 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01819727",
          "briefTitle": "An Open-Label Phase 3 Study of BMN 165 for Adults With PKU Not Previously Treated w/ BMN 165"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-05"
          },
          "completionDateStruct": {
            "date": "2015-11-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Phenylketonuria"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 261,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07290803",
          "briefTitle": "This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-11-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2034-01-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Atopic Dermatitis"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 1000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04555824",
          "briefTitle": "A Phase 1a Study of Thymosin Beta 4 in Healthy Volunteers"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-07-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-06-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Healthy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 54,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04306016",
          "briefTitle": "The Effects of a Model-based Sensory Stimulation Intervention on Preventing Delirium Among Intensive Care Unit Patients: A Randomised Controlled Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-07-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-10-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Delirium, Intensive Care Unit, Randomised Controlled Trial"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 152,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "90 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00367458",
          "briefTitle": "Randomized Placebo-Controlled Trial of Atorvastatin in HIV-Positive Patients Not on Antiretroviral Therapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-10-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2008-06-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "HIV"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 24,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06022913",
          "briefTitle": "Behavioural Activation for Bipolar Depression"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-11-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Bipolar Depression"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03294785",
          "briefTitle": "Comparative Effectiveness and Cost-effectiveness of Chuna Manual Therapy for Chronic Neck Pain"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-10-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-06-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Neck Pain"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 108,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "19 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03381742",
          "briefTitle": "Efficacy and Safety of Low-dose Ticagrelor"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-12-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-02-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Coronary Artery Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 3043,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00924066",
          "briefTitle": "Ixabepilone to Treat Cervical Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2013-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Cervical Carcinoma", "Cervical Adenocarcinoma", "Cervical Adenosquamous Carcinoma", "Cervical Carcinoma, Non-SquamousType"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 41,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03076554",
          "briefTitle": "A Pilot Study to Investigate the Safety and Clinical Activity of Avelumab (MSB0010718C) in Thymoma and Thymic Carcinoma After Progression on Platinum-Based Chemotherapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-04-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Thymoma", "Thymic Carcinoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 56,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03102034",
          "briefTitle": "Evaluating the Infectivity, Safety, and Immunogenicity of a Single Dose of a Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine (D46/NS2/N/ΔM2-2-HindIII) in RSV-Seronegative Infants 6 to 24 Months of Age"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-04-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-05-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Respiratory Syncytial Virus Infections"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 32,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "6 Months",
          "maximumAge": "24 Months"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04223778",
          "briefTitle": "Safety and Efficacy of a Switch to Doravirine/Islatravir in Participants With HIV-1 (MK-8591A-017)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-02-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-08-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "HIV Infection"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 672,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04185155",
          "briefTitle": "Simple Cognitive Task After Trauma EKUT RCT"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-12-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-07-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Post Traumatic Stress Disorder"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 16,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06132958",
          "briefTitle": "Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-12-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-01-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Endometrial Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 710,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02911142",
          "briefTitle": "Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-07-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-10-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Primary Effusion Lymphoma", "B-Cell Neoplasm"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 17,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05764356",
          "briefTitle": "Imapct of bioMarkers on Pharmacodynamics and Bleeding Risk of Direct Oral AntiCoagulants and Ticagrelor Study II"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-03",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Novel Oral Anticoagulants", "NOACs", "Rivaroxaban", "Apixaban", "Edoxaban", "Dabigatran", "Ticagrelor", "Pharmacodynamics", "Pharmacogenomics", "RNA Profile", "Bleeding", "Biomarker"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 2000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01225666",
          "briefTitle": "MOD-4023 (Long-Lasting Human Growth Hormone (hGH)) Study in Growth Hormone Deficient Adults (GHDA)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-08"
          },
          "completionDateStruct": {
            "date": "2012-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Adult Growth Hormone Deficiency"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 52,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "23 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02192541",
          "briefTitle": "Ganetespib and Ziv-Aflibercept in Refractory Gastrointestinal Carcinomas, Non-Squamous Non-Small Cell Lung Carcinomas, Urothelial Carcinomas, and Sarcomas"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-12-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-02-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Neoplasms"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 5,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "120 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03253744",
          "briefTitle": "Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-07-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-01-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Prostate Cancer", "Prostatic Neoplasm"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 17,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03755934",
          "briefTitle": "Efficacy and Safety of MEDI7352 in Participants With Painful Diabetic Neuropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-11-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-06-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Painful Diabetic Neuropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 112,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03388632",
          "briefTitle": "Recombinant Interleukin-15 in Combination With Checkpoint Inhibitors Nivolumab and Ipilimumab in People With Refractory Cancers"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-02-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-05-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Metastatic Solid Tumors", "Treatment-Refractory Cancers"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 31,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "120 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00267865",
          "briefTitle": "Chemotherapy and HAART to Treat AIDS-related Primary Brain Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-09-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-09-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "AIDS-Related-Primary Central Nervous System Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07052929",
          "briefTitle": "Study of ASP2957 in Male Participants With X-linked Myotubular Myopathy Who Need Ventilators"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-09-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-10-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "X-Linked Myotubular Myopathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 9,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "maximumAge": "36 Months"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01101295",
          "briefTitle": "The ITP-RITUX Cohort: Rituximab in Immune ThrombocytoPenia."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-04"
          },
          "completionDateStruct": {
            "date": "2017-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Purpura, Thrombocytopenic, Idiopathic", "Autoimmune Thrombocytopenia"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 250,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00184002",
          "briefTitle": "Doxorubicin (Doxil) Combined With Rituxan, Cyclophosphamide, Vincristine and Prednisone in Newly Diagnosed Aggressive Non-Hodgkin's Lymphomas"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2003-01-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2013-05-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Non-Hodgkin's Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 68,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01369875",
          "briefTitle": "Modified Tumor Infiltrating Lymphocytes for Metastatic Melanoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-06-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2012-02-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Metastatic Melanoma", "Skin Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04282239",
          "briefTitle": "Pectoral Nerves Block to Relieve Post-sternotomy Pain After Cardiac Surgery"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-03-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2022-07",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Pain, Postoperative", "Cardiac Surgery"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "19 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01270880",
          "briefTitle": "Hsp90 Inhibitor STA-9090 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-01"
          },
          "completionDateStruct": {
            "date": "2014-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Adenocarcinoma of the Prostate", "Hormone-resistant Prostate Cancer", "Recurrent Prostate Cancer", "Stage IV Prostate Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 18,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02514772",
          "briefTitle": "GP2013 Treatment in Patients With Active Rheumatoid Arthritis, Previously Treated With Rituxan® or MabThera®"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-07"
          },
          "completionDateStruct": {
            "date": "2016-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Rheumatoid Arthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 107,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01931098",
          "briefTitle": "Oral Pazopanib Plus Oral Topotecan Metronomic Antiangiogenic Therapy for Recurrent Glioblastoma Multiforme (A) Without Prior Bevacizumab Exposure and (B) After Failing Prior Bevacizumab"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-12-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-09-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Glioblastoma", "Glioblastoma Multiforme", "Gliosarcoma", "Brain Neoplasms", "Central Nervous System Neoplasms"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 35,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04818112",
          "briefTitle": "A Randomized Controlled Trial to Improve Mother-Infant Synchrony Among Women With Childhood Adversity"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-07-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-06-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Parent-Child Relations", "Maternal Behavior", "Infant Behavior"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 262,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04147312",
          "briefTitle": "Fufang E'Jiao Jiang Intervening Cancer-related Fatigue"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-10-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Cancer-related Fatigue"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 600,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05035212",
          "briefTitle": "Study to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-08-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-01-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Lower Respiratory Tract Illness"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 38861,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05840354",
          "briefTitle": "RTMS and Steroid Joint Steroid Injection in Chronic Spinal Pain"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-06-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Spinal Pain"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05190705",
          "briefTitle": "Loncastuximab Tesirine in WM"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-02-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-08-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Waldenstrom Macroglobulinemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 36,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01079182",
          "briefTitle": "Basic Documentation of Adalimumab (Humira) in Patients With Ankylosing Spondylitis (AS)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-01"
          },
          "completionDateStruct": {
            "date": "2014-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ankylosing Spondylitis"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 4681,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02019693",
          "briefTitle": "A Phase 2 Study of the MET Kinase Inhibitor INC280 in Papillary Renal Cell Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-01-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-12-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Kidney Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00924209",
          "briefTitle": "A Phase II Study of Neo-Adjuvant Gemcitabine, Cisplatin and Bevacizumab in Stage IIIA (N2) Non-Squamous Cell Non-Small Cell Lung Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2011-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["NSCLC", "Stage IIIA (N2)"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 7,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03376321",
          "briefTitle": "A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Hospitalized Participants With Influenza A Infection"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-01-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-04-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Influenza A"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 334,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "13 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03965533",
          "briefTitle": "Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of GSK2831781 After an Intravenous (IV) Dose in Healthy Japanese and Caucasian Subjects, and a Subcutaneous (SC) Dose in Healthy Caucasian Subjects"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-06-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-12-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Healthy Volunteers"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 36,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "MALE",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04538378",
          "briefTitle": "Olaparib (LYNPARZA) Plus Durvalumab (IMFINZI) in EGFR-Mutated Adenocarcinomas That Transform to Small Cell Lung Cancer (SCLC) and Other Neuroendocrine Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-07-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-02-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["EGFR-Mutated Non-Small-Cell Lung Carcinoma", "Small Cell/Neuroendocrine"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 4,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01474421",
          "briefTitle": "Safety and Efficacy of AQW051 in L-dopa Induced Dyskinesias in Patients With Parkinson's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-09-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2013-02-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Dyskinesias", "Drug-induced"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 71,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "30 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04491955",
          "briefTitle": "Phase II Trial of Combination Immunotherapy in Subjects With Advanced Small Bowel and Colorectal Cancers"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-09-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-08-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Small Bowel Cancers", "Colorectal Cancers"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 32,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05843812",
          "briefTitle": "Magnesium Sulfate in Bariatric Surgery"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-04-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Anesthesia and Analgesia", "Magnesium Sulfate", "Bariatric Surgery Candidate"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 104,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05321433",
          "briefTitle": "Tobacco Use and the Risk of COVID-19 and Adverse Outcomes"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-04-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-12-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["COVID-19", "Respiratory Tract Infections", "Infections", "Pneumonia, Viral", "Pneumonia", "Virus Diseases", "SARS-CoV-2 Infection"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 757585,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "20 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01967823",
          "briefTitle": "T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-10-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-04-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Melanoma", "Meningioma", "Breast Cancer", "Non-Small Cell Lung Cancer", "Hepatocellular Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 11,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "15 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00272779",
          "briefTitle": "BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-11"
          },
          "completionDateStruct": {
            "date": "2008-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "HIV Infections"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1057,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01968109",
          "briefTitle": "An Investigational Immuno-therapy Study to Assess the Safety, Tolerability and Effectiveness of Anti-LAG-3 With and Without Anti-PD-1 in the Treatment of Solid Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-11-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-02-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Neoplasms by Site"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1499,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02322190",
          "briefTitle": "Biomarkers in Acute Graft-Versus-Host Disease and Extracorporeal Photopheresis Added to Investigator Chosen Therapies of Steroid Refractory Acute GVHD"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-12-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-10-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Graft vs. Host Disease", "Graft vs Host Disease", "Graft-Versus-Host Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 5,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04816721",
          "briefTitle": "A Study to Evaluate EDP 938 Regimens in Children With RSV"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-04-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-08-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Respiratory Syncytial Virus (RSV)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 99,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "28 Days",
          "maximumAge": "36 Months"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00923936",
          "briefTitle": "Pilot Study of Liposomal Doxorubicin Combined With Bevacizumab Followed by Bevacizumab Monotherapy in Adults With Advanced Kaposi s Sarcoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-04-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-11-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Sarcoma, Kaposi"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 16,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07252544",
          "briefTitle": "Isosorbide Mononitrate and Butylphthalide to Reduce the Risk of Disability in Patients With Acute Lacunar Stroke (IMPACT)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-12-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-02-29",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Stroke, Lacunar", "Stroke, Acute Ischemic", "Cerebral Small Vessel Diseases"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 3156,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "30 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05217238",
          "briefTitle": "Median Effective Dose of Remifentanil for the Prevention of Pain Caused by the Injection of Rocuronium"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-12-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-03-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Rocuronium", "Injection Pain"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 70,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03403348",
          "briefTitle": "A First-In-Human Study of Orally Administered JNJ-64417184 to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses, and the Antiviral Activity of Multiple Doses in a Respiratory Syncytial Virus (RSV) Challenge Study in Healthy Participants"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-05-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-11-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Healthy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 130,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "55 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05042778",
          "briefTitle": "Is Auriculotherapy Responsible for Improvements on Anxiety Students' Prior and After Examinations?"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-09-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-12-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Anxiety"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 26,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00702689",
          "briefTitle": "Imatinib Mesylate to Treat Skin Changes in Patients With Chronic Graft-Versus-Host Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-12-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-02-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Sclerotic Graft Versus Host Disease", "Imatinib Mesylate"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "4 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02203513",
          "briefTitle": "A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-01-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-08-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Ovarian Cancer", "Breast Cancer", "Prostate Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 111,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06412055",
          "briefTitle": "Bidirectional Tuning of the AFO Stiffness"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-05-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-02-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Neuromuscular Disorders"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00333840",
          "briefTitle": "Safety and Efficacy of Imatinib Versus Interferon-α Plus Cytarabine in Patients With Newly Diagnosed Philadelphia Chromosome Positive Chronic Myelogenous Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2000-06"
          },
          "completionDateStruct": {
            "date": "2012-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Myelogenous Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1106,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04088318",
          "briefTitle": "A Study to Investigate OQL011 on VEGFR Inhibitor-Associated Hand-Foot Skin Reaction in Cancer Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-12-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Hand-Foot Skin Reaction (HFSR)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 170,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02859454",
          "briefTitle": "Avelumab for People With Recurrent Respiratory Papillomatosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-08-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-09-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Recurrent Respiratory Papillomatosis", "Juvenile Laryngeal Papilloma", "Laryngeal Papilloma, Recurrent", "Respiratory Papillomatosis", "Human Papilloma Virus"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 13,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04942210",
          "briefTitle": "Study on an Investigational Yellow Fever Vaccine Compared With YF-VAX in Adults in the USA"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-07-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-06-29",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Yellow Fever", "Healthy Volunteers"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 568,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02493751",
          "briefTitle": "A Study Of Avelumab In Combination With Axitinib In Advanced Renal Cell Cancer (JAVELIN Renal 100)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-10-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-03-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Renal Cell Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 55,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03727841",
          "briefTitle": "Marizomib for Recurrent Low-Grade and Anaplastic Supratentorial, Infratentorial, and Spinal Cord Ependymoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-01-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-04-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Anaplastic Ependymoma", "Ependymoma", "Ependymomas"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 4,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04091451",
          "briefTitle": "Safety and Immunogenicity Study of GlaxoSmithKline's Herpes Zoster Subunit Vaccine (HZ/su) When Given on a Two-dose Schedule to Adults at Least 50 Years of Age (YOA) With a Prior Episode of Herpes Zoster"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-09-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-02-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Herpes Zoster"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1430,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00306202",
          "briefTitle": "Study of Dasatinib in Children and Adolescents With Relapsed or Refractory Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-03-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-05-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 63,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Months",
          "maximumAge": "20 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04896073",
          "briefTitle": "Superenhancer Inhibitor Minnelide in Advanced Refractory Adenosquamous Carcinoma of the Pancreas (ASCP)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-03-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-03-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Adenosquamous Carcinoma of the Pancreas"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 16,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05203068",
          "briefTitle": "Specificity Trial of the Recombinant Tuberculosis Allergen in BCG Vaccinated Healthy Volunteers"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-11-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-01-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Tuberculosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 150,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "30 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02001051",
          "briefTitle": "Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-11-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-02-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Subclinical Hypercortisolism", "Cushing Syndrome", "Adrenal Neoplasm"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 4,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04663360",
          "briefTitle": "Medication Monitoring for Older Adults in Primary Care"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-01-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-10-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Polypharmacy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 19,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "64 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02798120",
          "briefTitle": "P3 Long Term Safety Study of Once Daily SB204 in Acne"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-05-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-04-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acne Vulgaris"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 601,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "9 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03701295",
          "briefTitle": "Pinometostat and Azacitidine in Treating Patients With Relapsed, Refractory, or Newly Diagnosed Acute Myeloid Leukemia With 11q23 Rearrangement"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-03-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-01-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-MLL", "Leukemia Cutis", "Recurrent Acute Myeloid Leukemia", "Refractory Acute Myeloid Leukemia"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04359095",
          "briefTitle": "Effectiveness and Safety of Medical Treatment for SARS-CoV-2 (COVID-19) in Colombia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-08-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-06-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 650,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01059786",
          "briefTitle": "Randomized Phase II Trial of Rituximab With Either Pentostatin or Bendamustine for Multiply Relapsed or Refractory Hairy Cell Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-07-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Hairy Cell Leukemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 69,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05648656",
          "briefTitle": "TXA Nebulization for the Treatment of Hemoptysis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-02-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-01-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Hemoptysis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03392987",
          "briefTitle": "A Safety and Efficacy Study of Cryopreserved OTL-200 for Treatment of Metachromatic Leukodystrophy (MLD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-01-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-01-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Lysosomal Storage Disease", "Metachromatic Leukodystrophy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "maximumAge": "6 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04610476",
          "briefTitle": "Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-10-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-10-19",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Psoriatic Arthritis", "Withdrawal", "Reduction"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 270,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02111863",
          "briefTitle": "Immunotherapy Using 41BB Selected Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-02-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-07-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Melanoma", "Skin Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 6,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      }
    ],
    "protocolSection.2": [
      {
        "identificationModule": {
          "nctId": "NCT01272908",
          "briefTitle": "A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Failed on One Prior Anti-TNF Therapy (RESET)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2006-07-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2009-03-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Rheumatoid Arthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 120,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03298399",
          "briefTitle": "Mesenchymal Stromal Cells for Haplo Hematopoietic Cell Transplantation for Sickle Cell Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-12-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-10-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Sickle Cell Disease"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01294358",
          "briefTitle": "Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-01-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2014-07-23",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Histologically or Cytologically Confirmed Pancreatic Ca", "Unresectable or Borderline Resectable Pancreatic Ca"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 7,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03467763",
          "briefTitle": "Trial of an Intervention to Improve Metformin Persistence and Adherence"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-02-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-08-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Metformin Adverse Reaction", "Tolerance"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 13,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07076849",
          "briefTitle": "Probiotic Supplementation in Optimizing Iron and Hematological Status Among Pregnant Females"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-10-30",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2030-11-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Iron Deficiency (ID)", "Pregnancy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 250,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "45 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04364178",
          "briefTitle": "Viral Specific T-Lymphocytes to Treat Adenovirus or CMV"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-08-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2032-01-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Adenovirus", "Cytomegalovirus Infections"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 25,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Month",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00923364",
          "briefTitle": "Pilot and Feasibility Study of Reduced-Intensity Hematopoietic Stem Cell Transplant for MonoMAC"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-05-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-02-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["MDS", "Immunodeficiency", "GATA2"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 19,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04878731",
          "briefTitle": "Study to Evaluate Safety and Tolerability of a Single Dose of PF-06741086 in Chinese Adult Participants With Severe Hemophilia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-04-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-08-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Severe Hemophilia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 6,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years",
          "maximumAge": "74 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05493631",
          "briefTitle": "A Phase 1b Study to Assess the Safety, Tolerability, PK and PD of MG1113 in Hemophilia Patient"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-08-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hemophilia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "19 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01559584",
          "briefTitle": "Phototoxic Doses of Ultraviolet A for Treatment of Alopecia Areata"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-03"
          },
          "completionDateStruct": {
            "date": "2014-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Alopecia Areata"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04428047",
          "briefTitle": "Evaluation of Bintrafusp Alfa in Operable and Untreated Head and Neck Squamous Cell Carcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-02-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-01-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Squamous Cell Carcinoma of Head and Neck"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 7,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05181618",
          "briefTitle": "A Study to Evaluate Overall Health, Physical Activity, and Joint Outcomes in Participants With Severe or Moderate Hemophilia A Without Factor VIII Inhibitors on Emicizumab Prophylaxis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-06-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-05-21",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Severe Hemophilia A", "Moderate Hemophilia A"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 136,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "13 Years",
          "maximumAge": "69 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05204602",
          "briefTitle": "Safety and Immunogenicity of COVID-19 Vaccine Booster in Patients With Liver Diseases"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-02-10",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2022-12-20",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["COVID-19", "Vaccine Reaction", "Liver Diseases"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 1000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01218867",
          "briefTitle": "CAR T Cell Receptor Immunotherapy Targeting VEGFR2 for Patients With Metastatic Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-11-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2015-12-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Metastatic Cancer", "Metastatic Melanoma", "Renal Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 24,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05384587",
          "briefTitle": "Asciminib Monotherapy, With Dose Escalation, for 2nd and 1st Line Chronic Myelogenous Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-11-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-10-17",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Chronic Myelogenous Leukemia - Chronic Phase"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 34,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01600677",
          "briefTitle": "Determining the Impact of a Medication Delivery Unit on Medication Adherence of Adults With Common Cardiac Conditions"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-05"
          },
          "completionDateStruct": {
            "date": "2013-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Medication Adherence", "Medication Nonadherence", "Adverse Reaction to Drug"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 11,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02728934",
          "briefTitle": "Comparative and Pragmatic Study of Golimumab Intravenous (IV) (Simponi Aria) Versus Infliximab (Remicade) in Rheumatoid Arthritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-02-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-01-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Arthritis, Rheumatoid"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 1279,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04579666",
          "briefTitle": "MERIDIAN: A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults With Amyotrophic Lateral Sclerosis (ALS)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-09-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-07-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Amyotrophic Lateral Sclerosis", "Motor Neuron Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 249,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03143101",
          "briefTitle": "Evaluate the Shedding and Immunogencity of Different Formulations of FluMist in Children 24 to <48 Months of Age"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-05-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-09-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Influenza", "Healthy"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "24 Months",
          "maximumAge": "47 Months"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00772941",
          "briefTitle": "Drug Use Investigation Of Varenicline (Regulatory Post Marketing Commitment Plan)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-02"
          },
          "completionDateStruct": {
            "date": "2012-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Smoking Cessation"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 3939,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04434092",
          "briefTitle": "A Study Evaluating the Efficacy and Safety of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Not Previously Treated With Complement Inhibitors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-10-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-09-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Paroxysmal Nocturnal Hemoglobinuria"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 210,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03531814",
          "briefTitle": "Medication Adherence in Children, Adolescents and Adults With Neurofibromatosis Type 1(NF1) on Clinical Treatment Trials"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-10-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-03-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Neurofibromatosis 1", "Neurofibroma, Plexiform"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "3 Years",
          "maximumAge": "59 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06489548",
          "briefTitle": "Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-04",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Dementia", "Alzheimers Disease", "Mild Cognitive Impairment Due to Alzheimer's Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 16,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "60 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01927848",
          "briefTitle": "Improving Gait in Persons With Knee Related Mobility Limitations by Rosenoids® Food Supplement: a Randomized Double-blind Placebo-controlled Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-09"
          },
          "completionDateStruct": {
            "date": "2014-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Knee Related Walking Limitations"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00547521",
          "briefTitle": "Phase IIIB Subcutaneous Abatacept Monotherapy Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-12"
          },
          "completionDateStruct": {
            "date": "2014-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Rheumatoid Arthritis (RA)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 119,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03016377",
          "briefTitle": "Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory ALL"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-03-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2037-09-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Lymphoblastic Leukemia", "Immune System Diseases", "Immunoproliferative Disorders"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 17,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "3 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01121536",
          "briefTitle": "Extension Study of the Safety and Efficacy of Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-04-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2013-10-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Depression"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 867,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04889209",
          "briefTitle": "Delayed Heterologous SARS-CoV-2 Vaccine Dosing (Boost) After Receipt of EUA Vaccines"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-05-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-06-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 867,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02603419",
          "briefTitle": "Avelumab In Patients With Previously Treated Advanced Stage Classical Hodgkin's Lymphoma (JAVELIN HODGKINS)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-03-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-04-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hodgkins Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 34,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00087568",
          "briefTitle": "A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Ribavirin in Patients With Chronic Hepatitis C (CHC) Previously Treated With PEG-Intron + Ribavirin"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2003-01"
          },
          "completionDateStruct": {
            "date": "2006-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hepatitis C, Chronic"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 57,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03803774",
          "briefTitle": "Birinapant and Intensity Modulated Re-Irradiation Therapy in Treating Patients With Locally Recurrent Head and Neck Squamous Cell Carcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-09-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-07-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Locally Recurrent Head and Neck Squamous Cell Carcinoma", "Nasopharyngeal Squamous Cell Carcinoma", "Sinonasal Squamous Cell Carcinoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 13,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06909110",
          "briefTitle": "Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-04-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2032-01-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Adenovirus", "Cytomegalovirus Infections", "Epstein-Barr Virus Infections"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 25,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Month",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03020160",
          "briefTitle": "A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Emicizumab Given Every 4 Weeks in Participants With Hemophilia A"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-01-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-06-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hemophilia A"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 48,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02649855",
          "briefTitle": "Docetaxel and PROSTVAC for Metastatic Castration-Sensitive Prostate Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-01-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-12-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Prostate Cancer", "Prostate Neoplasms", "Neoplasms, Prostatic"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 74,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02712671",
          "briefTitle": "Testing for Tuberculosis in the United Kingdom HIV Infected Population"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-06"
          },
          "completionDateStruct": {
            "date": "2024-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["HIV", "Latent Tuberculosis"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 300,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06272500",
          "briefTitle": "Safety and Efficacy Study of Betaine Hydrochloride in Treating Hypergastrinemia in Patients With Autoimmune Gastritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-02-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-05-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Autoimmune Gastritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 60,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03315871",
          "briefTitle": "Combination Immunotherapy in Biochemically Recurrent Prostate Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-03-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-06-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Prostate Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06870344",
          "briefTitle": "IGHID 12334 - After the Flood: Optimal Strategies to Prevent Malaria Epidemics Caused by Severe Flooding"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-03-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-07-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Malaria Infection", "Malaria Falciparum"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 36000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "0 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04890509",
          "briefTitle": "A Study of Bemcentinib for the Treatment of COVID-19 in Hospitalised Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-10-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-05-25",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 115,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01403948",
          "briefTitle": "BI 836826 Dose Escalation in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma (NHL)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-08-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-02-28",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Lymphoma, Non-Hodgkin"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 48,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07247370",
          "briefTitle": "Ketamine-Enhanced Therapy for Individuals With Alcohol Use Disorder and Depression: A Pilot Study (KET-DUAL)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-12-10",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-12-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Alcohol Use Disorder (AUD)", "Major Depressive Disorder (MDD)", "Comorbidities and Coexisting Conditions"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 20,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03451773",
          "briefTitle": "M7824 (MSB0011359C) in Combination With Gemcitabine in Adults With Previously Treated Advanced Adenocarcinoma of the Pancreas"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-05-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-05-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Cancer of Pancreas", "Pancreas Cancer", "Pancreatic Adenocarcinoma", "Pancreatic Cancer", "Pancreatic Neoplasms"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 7,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06871488",
          "briefTitle": "Predictors of Improvements in Irritability and Aggression in Children With ADHD Treated With CNS Stimulants"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2026-01-15",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2030-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["ADHD - Attention Deficit Disorder With Hyperactivity", "Irritability", "Aggression Childhood"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 136,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "7 Years",
          "maximumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01239368",
          "briefTitle": "Th1/Tc1 Immunotherapy Following Stem Cell Transplantation in Multiple Myeloma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-11-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-08-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Myeloma, Plasma-Cell", "Myeloma-Multiple", "Myelomatosis"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 34,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01305408",
          "briefTitle": "Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-03"
          },
          "completionDateStruct": {
            "date": "2013-07",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Depression"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 399,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03110952",
          "briefTitle": "TDENV PIV and LAV Dengue Prime-boost Strategy Using AS03B Adjuvant"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-01"
          },
          "completionDateStruct": {
            "date": "2018-04",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Dengue"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "39 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01547806",
          "briefTitle": "Collection of Transplant Stem Cells for Plasma Cell Myeloma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-02-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-01-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Plasma Cell Myeloma", "Multiple Myeloma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 49,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05522933",
          "briefTitle": "Development and Evaluation of an Online Multidimensional Musculoskeletal Health Programme"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-08-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-01-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Occupational Health"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01827384",
          "briefTitle": "MPACT Study to Compare Effects of Targeted Drugs on Tumor Gene Variations"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-01-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-10-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Advanced Malignant Solid Neoplasm"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 208,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02101281",
          "briefTitle": "Safety and Efficacy of rhNGF Eye Drops at Different Doses in Patients With Dry Eye"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-01-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2015-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Dry Eye Syndrome"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06147999",
          "briefTitle": "Impact of a Biophoton Therapy on Patients With Brain Disorders"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-11-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-11-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Brain Disorders - Alzheimer's Disease, Dementia, Parkinson's Disease, Traumatic Brain Injury"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 80,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03093155",
          "briefTitle": "Evaluation of Weekly Ixabepilone With or Without Biweekly Bevacizumab"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-04-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-12-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Epithelial Ovarian Cancer", "Fallopian Tube Cancer", "Primary Peritoneal Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 78,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04783935",
          "briefTitle": "Extension to the MAGNIFY MS Trial on Mavenclad® (Magnify MS Extension)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-03-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-09-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Sclerosis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 219,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05025514",
          "briefTitle": "Retrospective Study of COVID-19 Vaccines in Patients Undergoing Immunotherapy for Cancer."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-10-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-06-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Cancer", "Immunotherapy"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 500,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01967576",
          "briefTitle": "Phase II Study of Axitinib (AG-013736) With Evaluation of the VEGF-pathway in Metastatic, Recurrent or Primary Unresectable Pheochromocytoma/Paraganglioma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-10-19",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-12-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Pheochromocytoma", "Paraganglioma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 14,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04313400",
          "briefTitle": "Topically Applied AMTX-100 CF for Adult Patients With Mild to Moderate Atopic Dermatitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-03-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-01-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Atopic Dermatitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 91,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03436745",
          "briefTitle": "The Effects of Castration on the Pharmacokinetics of Zolpidem After Single Dose Administration In Men With Prostate Cancer Undergoing Androgen Deprivation Therapy Compared to Normal Healthy Females"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-01-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-01-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Prostatic Neoplasms"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05012865",
          "briefTitle": "Current Treatment Outcomes in Japanese RCC Patients Treated With Avelumab Plus Axitinib as First-line Therapy: Retrospective Study (J-DART)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-09-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-01-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Renal Cell Carcinoma"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 48,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "20 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01993719",
          "briefTitle": "Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Melanoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-12-12",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-07-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Metastatic Melanoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 33,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00972309",
          "briefTitle": "A Pilot Study of Vaccination With Epitope-Enhanced TARP Peptide and TARP Peptide-Pulsed Dendritic Cells in the Treatment of Stage D0 Prostate Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-05-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2015-02-04",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Prostate Specific Antigens", "Prostate Neoplasms"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 41,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years",
          "maximumAge": "100 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04113044",
          "briefTitle": "Go Fit Fast, Recovery Trajectory Using PROMIS®, Linking PROMIS®"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-02-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Hip Fractures", "Tibial Fractures", "Ankle Fractures", "Humeral Fracture, Proximal", "Distal Radius Fracture"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 3500,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01675141",
          "briefTitle": "Lenalidomide Maintenance Therapy for Multiple Myeloma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-08-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-03-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Multiple Myeloma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 11,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00891046",
          "briefTitle": "An Open-label Extension Study of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis and Active Systemic Manifestations Manifestations and Response Characterization Study in Canakinumab Treatment-naïve Patients With Active SJIA With and Without Fever."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-09"
          },
          "completionDateStruct": {
            "date": "2014-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Systemic Juvenile Idiopathic Arthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 270,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years",
          "maximumAge": "19 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06558773",
          "briefTitle": "GSL Synthetase Inhibitor Plus Immune Checkpoint Inhibitor and/or Regorafenib in Previously Treated pMMR/MSS CRC."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-09-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-08-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Colorectal Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 120,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02627456",
          "briefTitle": "Safety, Immunogenicity, and Protective Efficacy of Radiation Attenuated Plasmodium Falciparum NF54 Sporozoites in Healthy African Adults in Mali"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-12-09"
          },
          "completionDateStruct": {
            "date": "2018-07-03",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Malaria"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 409,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04085172",
          "briefTitle": "A Study of TAK-503 in Children and Teenagers With Attention Deficit Hyperactivity Disorder (ADHD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-09-18",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-09-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Attention Deficit Hyperactivity Disorder"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 396,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "6 Years",
          "maximumAge": "17 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05289037",
          "briefTitle": "COVID-19 Variant Immunologic Landscape Trial (COVAIL Trial)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-03-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-11-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1270,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01146652",
          "briefTitle": "Long Term Evaluation of Sarilumab in Rheumatoid Arthritis Patients (SARIL-RA-EXTEND)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-06-21",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-12-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Rheumatoid Arthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2023,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03988426",
          "briefTitle": "Study to Evaluate the Efficacy, Tolerability and Safety of Octanorm in Patients With Primary Immunodeficiency Diseases"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-03-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-01-26",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Primary Immune Deficiency Disorder"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 25,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06932120",
          "briefTitle": "Technology-supported Interventions for Prolonged Grief Disorder (PGD)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-09-08",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-09-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Prolonged Grief Disorder (PGD)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 141,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03591224",
          "briefTitle": "Pharmacogenomic Testing to Optimize Antidepressant Drug Therapy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-04-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-12-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Depression", "Anxiety", "Major Depressive Disorder", "Generalized Anxiety Disorder", "Mood Disorders"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 213,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01467479",
          "briefTitle": "A Study to Treat Subjects With Telaprevir, Ribavirin, and Peginterferon Who Are Coinfected With HIV and Hepatitis C Virus (HCV)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-12"
          },
          "completionDateStruct": {
            "date": "2014-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hepatitis C"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 185,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01445535",
          "briefTitle": "Phase 1 Trial of Siplizumab and Dose-Adjusted EPOCH-Rituximab in T- and NK-Cell Lymphomas"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-01-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-10-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["T-Cell Peripheral Lymphoma", "Gamma Delta Hepatosplenic T-Cell Lymphoma", "Subcutaneous Panniculitis-Like T-Cell Lymphoma", "NK T-Cell Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "120 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02691910",
          "briefTitle": "Efficacy of Chloroquine (CQ) Alone Compared to Concomitant CQ and Primaquine for Plasmodium Vivax Infection"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-08"
          },
          "completionDateStruct": {
            "date": "2015-09",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Malaria, Vivax"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 204,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "5 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00941655",
          "briefTitle": "Prospective Randomized Trial Comparing Gastrectomy, Metastasectomy Plus Systemic Therapy Versus Systemic Therapy Alone: GYMSSA Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-07-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2012-06-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Gastric Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03967223",
          "briefTitle": "Master Protocol to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-12-31",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-07-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Neoplasms"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 103,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "10 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00635089",
          "briefTitle": "Open-Label Extension Study of Reslizumab in Pediatric Subjects With Eosinophilic Esophagitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2008-07"
          },
          "completionDateStruct": {
            "date": "2012-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Eosinophilic Esophagitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 190,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "5 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01871727",
          "briefTitle": "A Trial of E7777 in Persistent and Recurrent Cutaneous T-Cell Lymphoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-05-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-12-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Persistent or Recurrent Cutaneous T-Cell Lymphoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 112,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01077622",
          "briefTitle": "A Phase I/II, a Single Arm, Open-label Study of Ofatumumab (GSK1841157) in Patients With Previously Treated Chronic Lymphocytic Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-09-01"
          },
          "completionDateStruct": {
            "date": "2011-04-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Leukaemia, Lymphocytic, Chronic"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 10,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "20 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05416073",
          "briefTitle": "Effect of Esketamine on Abdominal Pain During TACE-HAIC in Patients With Hepatocellular Carcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-06-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-04-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Hepatocellular Carcinoma", "Transarterial Chemoembolization", "Hepatic Arterial Infusion Chemotherapy", "Pain"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 70,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05839236",
          "briefTitle": "COVID-19 Vaccination Detoxification in LDL-C"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-05-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-07-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["COVID-19 Stress Syndrome", "COVID-19 Vaccine Adverse Reaction", "COVID-19-Associated Thromboembolism", "COVID-19 Post-Intensive Care Syndrome", "COVID-19-Associated Stroke", "COVID-19 Respiratory Infection"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "MALE",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04147533",
          "briefTitle": "Efficacy and Safety of TKIs' Withdrawal After a Two-step Dose Reduction in Patients with Chronic Myeloid Leukemia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-06-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Chronic Myeloid Leukemia, Chronic Phase", "Withdrawal;Drug"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 150,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03478904",
          "briefTitle": "Study to Compare Capsule and Liquid Formulations of Enzalutamide After Single Dose Administration Under Fasting Conditions in Prostate Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-03-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-11-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Prostate Cancer"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "MALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07189091",
          "briefTitle": "CReep and Maintenance flUid Sodium Chloride ADministration rEduction in cRitically Ill adultS"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-09",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-07-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Critical Care, Intensive Care", "Fluid Accumulation", "Fluid and Electrolyte Imbalance", "Critical Illness", "Fluid Balance Outcomes"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 640,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03300843",
          "briefTitle": "Ability of a Dendritic Cell Vaccine to Immunize Melanoma or Epithelial Cancer Patients Against Defined Mutated Neoantigens Expressed by the Autologous Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-04-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-09-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Melanoma", "Gastrointestinal Cancer", "Breast Cancer", "Ovarian Cancer", "Pancreatic Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04885413",
          "briefTitle": "An Open-label, Single Arm, Phase II Trial of Niraparib in Combination With Anti-PD1（Programmed Cell Death Protein 1） Antibody in Recurrent/ Advanced Stage Endometrial Cancer Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-07-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-06-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Recurrent/ Advanced Stage Endometrial Cancer Patients"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 37,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03905135",
          "briefTitle": "Interleukin-15 (IL-5) in Combination With Avelumab (Bavencio) in Relapsed/Refractory Mature T-cell Malignancies"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-06-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-05-17",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Peripheral T-cell Lymphoma NOS", "Mycosis Fungoides", "Sezary Syndrome", "Anaplastic Large Cell Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 8,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03721978",
          "briefTitle": "REVEAL 2 Trial (Evaluation of VGX-3100 and Electroporation for the Treatment of Cervical HSIL)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-02-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-09-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Cervical Dysplasia", "Cervical High Grade Squamous Intraepithelial Lesion", "HSIL"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 203,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02948426",
          "briefTitle": "Intraperitoneal Infusion of Autologous Monocytes With Sylatron (Peginterferon Alfa-2b) and Actimmune (Interferon Gamma-1b) in Women With Recurrent or Refractory Ovarian Cancer, Fallopian Tube Cancer or Primary Peritoneal Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-02-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-09-29",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Fallopian Tube Cancer", "Ovarian Cancer", "Primary Peritoneal Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 18,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "FEMALE",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03370263",
          "briefTitle": "BENLYSTA® Special Drug Use Investigation"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-01-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-06-26",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Systemic Lupus Erythematosus"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 600,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06567080",
          "briefTitle": "JWCAR201 for the Treatment of Hematology Malignancy and Autoimmune Diseases"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-09",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2027-03",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["B-cell Tumors", "Autoimmune Diseases", "Lupus Erythematosus, Systemic", "Large B-cell Lymphoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04827979",
          "briefTitle": "Daratumumab and Belatacept for Desensitization"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-11-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2028-04-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Highly Sensitized Prospective Kidney Transplant Recipients"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 15,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04150562",
          "briefTitle": "Avelumab (Bavencio) With IL-15 in Subjects With Clear-Cell Renal Carcinoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-05-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-09-16",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Clear-Cell Renal Carcinoma"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03027388",
          "briefTitle": "Protein Phosphatase 2A Inhibitor, in Recurrent Glioblastoma"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-01-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-08-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Astrocytoma, Grades II, III and IV", "Glioblastoma Multiforme", "Giant Cell Glioblastoma", "Glioma", "Oligodendrogliomas"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 7,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01921088",
          "briefTitle": "Real-Time Functional Magnetic Resonance Imaging Neurofeedback for Regulation of Psychophysiological Functions"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-08"
          },
          "completionDateStruct": {
            "date": "2019-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Stress", "Blood Pressure"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 31,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "MALE",
          "minimumAge": "18 Years",
          "maximumAge": "65 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05685953",
          "briefTitle": "A Randomized, Phase I Study of DNA Vaccine OC-007 as a Booster Dose of COVID-19 Vaccine"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-02-08",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-03-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["COVID-19 Respiratory Infection", "COVID-19 Vaccine Adverse Reaction"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 16,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03002623",
          "briefTitle": "CUDC-907 Treatment in People With Metastatic and Locally Advanced Thyroid Cancer"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-12-22",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-02-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Thyroid Neoplasms", "Poorly Differentiated and Undifferentiated Thyroid Cancer", "Differentiated Thyroid Cancer"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 7,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03275051",
          "briefTitle": "Long-term Follow-up of Subjects Treated With OTL-300 for Transfusion Dependent Beta-thalassemia Study (TIGET-BTHAL)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-10-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-06-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Beta Thalassaemia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 9,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "3 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04166383",
          "briefTitle": "VB-111 in Combination With Nivolumab in People With Metastatic Colorectal Cancer (mCRC)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-08-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-12-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Metastatic Colorectal Cancer", "Colorectal Neoplasms", "Colorectal Carcinoma", "Colorectal Cancer With Hepatic Metastases", "Colorectal Tumors"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 14,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04473053",
          "briefTitle": "DEFINE - Evaluating Therapies for COVID-19"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-07-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-04-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "COVID-19"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 71,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years"
        }
      }
    ]
  }
}
